ARTICLE | Company News
MDG amends SCH deal
November 5, 2001 8:00 AM UTC
MediGene (NMarkt:MDG) said it had amended its license and development agreement with Schering (FSE:SCH; SHR) to develop treatments for pre-cancerous cervical lesions (see BioCentury, March 27, 2000)....